Contact

Please use this form to send email to PR contact of this press release:
Next Generation BioPharma with Advanced Treatments for Anemia & FDA-Approved Therapies: Rockwell Medical (NASDAQ: RMTI)

TO:
Dr. Russell H. Ellison M.Sc., M.D., MSc. Pres, CEO & Directo
Rockwell Medical, Inc.
+1 248-960-9009

FROM:
Your Name:
Your Email:	Please check your email address!
Subject:
Message:
Confirmation code:	Please, do not fill this field.
Confirmation version code:	Please, do not change this field.
Javascript data:	Please, do not fill if your javascript is turned off.
Please type in the code you see in the image. Or click Send Email to generate another image instead.
	SEND EMAIL